Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials

Published:2022-01-05 Issue: Volume: Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Sim Ruth¹^ORCID,Chong Chun Wie¹^ORCID,Loganadan Navin K.²^ORCID,Fong Alan Y. Y.³^ORCID,Navaravong Leenhapong⁴^ORCID,Hussein Zanariah⁵^ORCID,Khunti Kamlesh⁶^ORCID,Lee Shaun Wen Huey¹⁷⁸⁹^ORCID

Affiliation:

1. School of Pharmacy Monash University Malaysia Subang Jaya Selangor Malaysia

2. Department of Pharmacy Putrajaya Hospital Putrajaya Malaysia

3. Department of Cardiology, and Clinical Research Centre Sarawak General Hospital Sarawak Malaysia

4. Division of Cardiovascular Medicine Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah USA

5. Department of Medicine Putrajaya Hospital Putrajaya Malaysia

6. Leicester Diabetes Centre University of Leicester Leicester UK

7. School of Pharmacy Faculty of Health and Medical Sciences Taylor’s University Subang Jaya Selangor Malaysia

8. Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO) Health and Well‐being Cluster Monash University Malaysia Bandar Sunway Selangor Malaysia

9. Center for Global Health University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14780

Reference78 articles.

1. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

2. Intensive glucose lowering and cardiovascular disease prevention in diabetes;Mazzone T;Circulation,2010

3. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

4. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review;Cells;2024-09-05

2. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management;Diabetologia;2024-08-19

3. Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data;BMJ;2024-05-08

4. A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures;Acta Diabetologica;2024-05-07

5. Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk;Nature Cardiovascular Research;2024-04-03